Ramharter, Michael
Djimde, Abdoulaye A.
Borghini-Fuhrer, Isabelle
Miller, Robert
Shin, Jangsik
Aspinall, Adam
Richardson, Naomi
Wibberg, Martina
Fleckenstein, Lawrence
Arbe-Barnes, Sarah
Duparc, Stephan
Clinical trials referenced in this document:
Documents that mention this clinical trial
Safety and efficacy of pyronaridine–artesunate paediatric granules in the treatment of uncomplicated malaria in children: insights from randomized clinical trials and a real-world study
https://doi.org/10.1186/s12936-024-04885-3
Documents that mention this clinical trial
Safety and efficacy of pyronaridine–artesunate paediatric granules in the treatment of uncomplicated malaria in children: insights from randomized clinical trials and a real-world study
https://doi.org/10.1186/s12936-024-04885-3
Documents that mention this clinical trial
Safety and efficacy of pyronaridine–artesunate paediatric granules in the treatment of uncomplicated malaria in children: insights from randomized clinical trials and a real-world study
https://doi.org/10.1186/s12936-024-04885-3
Documents that mention this clinical trial
Safety and efficacy of pyronaridine–artesunate paediatric granules in the treatment of uncomplicated malaria in children: insights from randomized clinical trials and a real-world study
https://doi.org/10.1186/s12936-024-04885-3
Funding for this research was provided by:
Medicines for Malaria Venture
Article History
Received: 29 September 2023
Accepted: 20 February 2024
First Online: 28 February 2024
Declarations
:
: All patients, or their parents/guardians, provided written informed consent, and children able to understand the study gave signed assent. Ethics approval for the individual studies was granted as follows. SP-C-003-05: Gabon, Ethics Committee of the International Foundation for the Albert Schweitzer Hospital in Lambaréné. SP-C-007-07: Burkina Faso, Comité national d’éthique, Ministère de la Santé—Ministère des enseignements secondaires supérieurs et de la recherche scientifique—Comité d’Ethique pour la recherche en Santé; Democratic Republic of Congo, Ministère de l’Enseignement Supérieur et Universitaire, Ecole de santé Publique, Comité d’Ethique Université de Kinshasa, faculté de Médecine; Côte d’Ivoire, Ministère de la Santé et de l’Hygiène Publique—Comité National d’Ethique des Sciences de la Vie et de la Santé (CNESVS); Kenya, Kenyatta National Hospital Ethic Committee; Mali, Ministère de l’Education Nationale, Comité Institutionnel d’Ethique de la Faculté de Médicine de Pharmacie et d’Odonto Stomatologie Université de Bamako; The Philippines, Research Institute for Tropical Medicine Institutional/Ethical Review Board; Gabon, Comité d’Ethique Régional Indépendant de Lambaréné (CERIL). SP-C-013-11: Mali, Faculté de Médicine de Pharmacie et d'Odonto Stomatologie; Burkina Faso, Ministère de la Santé/Ministère de la Recherche Scientifique et de l’Innovation; Guinea, Comité National d’Ethique pour la Recherche en Santé. SP-C-021-15: Cameroon, Comité National d’Ethique de la Recherche pour la Santé Humaine; Democratic Republic of Congo, Comité d’Ethique de l’Université Protestante au Congo; Gabon, Comité Nationale d’Ethique et de la Recherche Scientifique and Comité d’Ethique Institutionnel Albert Schweitzer Hospital, Lambaréné; Côte d’Ivoire, Comité Nationale d’Ethique et de la Recherche Scientifique and Comité National d’Ethique des Sciences de la Vie et de Santé; and Republic of Congo, Comité d'éthique institutionnel de la Fondation Congolaise pour la Recherche Médicale.
: Not applicable.
: Stephan Duparc, Isabelle Borghini-Fuhrer and Adam Aspinall are employees of Medicines for Malaria Venture. Sarah Arbe-Barnes and Robert Miller are employees of Artemida Pharma. Jangsik Shin is an employee of Shin Poong Pharm. Co. Ltd. Naomi Richardson is an employee of Magenta Communications Ltd. which received funds from Medicines for Malaria Venture associated with this study. Martina Wibberg is an employee of DATAMAP GmbH which received funds from Medicines for Malaria Venture associated with this study. Michael Ramharter, Abdoulaye Djimde and Lawrence Fleckenstein declare no conflict of interest.